Publications by authors named "Ryan E Morgan"

Claim this Profile
C
Considerations and derivations of permitted daily exposure limits for impurities from intravitreal pharmaceutical products.
Yi Yu Rice, David G Dolan, Suren B Bandara, Ryan E Morgan, Michael Garry

Regul Toxicol Pharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal complications in pediatric lung transplant recipients: Incidence, risk factors, and effects on patient outcomes.
Timothy Klouda, Morgan Ryan E, Jessica Brie Leonard, Dawn Freiberger, Levent Midyat

Pediatr Transplant· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-center preclinical study of gadoxetate DCE-MRI in rats as a biomarker of drug induced inhibition of liver transporter function.
Anastassia Karageorgis, Stephen C Lenhard, Brittany Yerby, Mikael F Forsgren, Serguei Liachenko, Ryan E Morgan

PLoS One· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravital Multiphoton Microscopy with Fluorescent Bile Salts in Rats as an In Vivo Biomarker for Hepatobiliary Transport Inhibition.
Jennifer Ryan, Ryan E Morgan, Yuan Chen, Laurie P Volak, Robert T Dunn

Drug Metab Dispos· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Ryan E Morgan, Carlo J van Staden, Yuan Chen, Natarajan Kalyanaraman, Jackson Kalanzi

Toxicol Sci· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membrane vesicle ABC transporter assays for drug safety assessment.
Carlo J van Staden, Ryan E Morgan, Bharath Ramachandran, Yuan Chen, Paul H Lee

Curr Protoc Toxicol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Ryan E Morgan, Michael Trauner, Carlo J van Staden, Paul H Lee, Bharath Ramachandran

Toxicol Sci· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro assays and biomarkers for drug-induced phospholipidosis.
David K Monteith, Ryan E Morgan, Bartley Halstead

Expert Opin Drug Metab Toxicol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical flow cytometric biomarker strategy: validation of peripheral leukocyte phospholipidosis using Nile red.
Bartley W Halstead, Craig M Zwickl, Ryan E Morgan, David K Monteith, Craig E Thomas

J Appl Toxicol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis